Hepatitis E: New Clinical and Public Health Problem on the Western World? Review
Journal Title: Archives of Hepatitis Research - Year 2017, Vol 3, Issue 1
Abstract
Until recently, the occurrence of Hepatitis E in the western hemisphere did not amount to a clinical concern, due to its benign and usually sub-clinical evolution, as opposed to Asia and Africa, where large epidemies with high levels of lethality occur. More sensible diagnostic exams have shown a high prevalence of the infection through genotype 3 in the eastern hemisphere, with reports of hepatic infection, cirrhosis, and extremely severe systemic [1-3] and neurological extra-hepatic manifestations, especially on immunosuppressed patients [4-6]. Hepatitis E: an emerging infection in developed countries [7], suggesting the occurrence of a new and important clinical and public health problem [3,8].
Authors and Affiliations
Focaccia Roberto
Keywords
Related Articles
- EP ID EP559381
- DOI 10.17352/ahr.000011
- Views 40
- Downloads 0
Current Trends of Combination Therapy in Chronic Hepatitis B Management in China
In the past decade, five oral nucleos(t)ide analogs and two formulations of pegylated interferon alpha have been approved for the treatment of chronic hepatitis B (CHB). Due to low personal income and inadequate health c...
The Potential of Liver Fibrosis Indexes/Scores for the Screening of Cryptic Liver Fibrosis in Patients with NASH Risk Factors: A Case Report
The unintentional discovery of cirrhosis in a patient with prostate cancer lead us to enquire if some of the indexes/scored designed for the evaluation of liver fibrosis/cirrhosis, in Chronic Hepatitis C patients, could...
Non-Alcoholic Fatty Liver Disease Frequency among Healthy Blood Donors in the West of Iran
Objectives: To investigate the prevalence of NAFLD as well as the determination of associated metabolic abnormalities in Iranian blood donors. The aim of this study was to review cases of non-alcoholic fatty liver diseas...
Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adve...
Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of fatty liver, characterized by the accumulation of fat in the hepatocytes in the absence of alcohol consumption. The spectrum of th...